Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Etoposide × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

Carboplatin 5 osimertinib 4 amivantamab 4 Specimen Handling 4 Nivolumab 4 lazertinib 3 Pemetrexed 3 Magnetic Resonance Spectroscopy 3 trametinib 2 talquetamab 2 niraparib 2 ipatasertib 2 erdafitinib 2 daratumumab 2 dabrafenib 2 atezolizumab 2 apalutamide 2 X-Rays 2 Prednisone 2 Oxaliplatin 2 Midazolam 2 Lenalidomide 2 Immunoglobulin G 2 Disulfides 2 Dexamethasone 2 Dasatinib 2 Brentuximab Vedotin 2 Bortezomib 2 Ado-Trastuzumab Emtansine 2 Abiraterone Acetate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03043872 2026-04-22

CASPIAN

AstraZeneca

Phase 3 Active not recruiting

987 enrolled 42 charts 1 FDA

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡